ClinicalTrials.Veeva

Menu

Effectiveness of Speech Therapy for Lip-reading in Patients With Hearing Aids: SCED Study (SCEDuLL)

Pasteur Institute logo

Pasteur Institute

Status

Not yet enrolling

Conditions

Hearing Loss, Bilateral or Unilateral

Treatments

Other: Speechreading training

Study type

Observational

Funder types

Industry
Other

Identifiers

NCT07028658
2024-135_SCEDuLL
2025-A00506-23 (Other Identifier)

Details and patient eligibility

About

This study aims to investigate whether lip reading rehabilitation improves viseme recognition in individuals with hearing impairments who use hearing aids.

Enrollment

8 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient aged 18 or older
  • Affiliated with a social security system
  • Moderate to severe bilateral post-lingual hearing loss, fitted with hearing aids for more than 6 months
  • Wearing hearing aids for a minimum of 8 hours/day on average over the past month
  • Intelligibility in quiet > 80% correct responses at 60 dB (Lafon cochlear list)
  • Difficulty in noisy environments rated > 6 on a 0-10 EVA scale
  • French language comprehension level of at least B1 CEFR (Common European Framework of Reference for Languages)
  • Willing to participate in speech therapy rehabilitation at a rate of 2 sessions per week

Exclusion criteria

  • Patient who has already undergone speech therapy rehabilitation as part of their hearing loss treatment
  • Diagnosis of neurodegenerative disease or history of brain injury (traumatic brain injury, stroke, tumor, meningitis, etc.)
  • Uncorrected vision or visual impairment affecting lip reading (e.g. AMD, glaucoma, unoperated cataract, etc.)
  • Presence of severe tinnitus (score > 56) on the Tinnitus Handicap Inventory (THI) questionnaire
  • Significant cognitive impairment (CODEX C or D) or Montreal Cognitive Assessment (MOCA) score < 23

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems